News & Events  Press Releases

Center Point Clinical Services Names Tim Slavin New Senior Director of Clinical Accounts

September 14, 2016

Malvern, Pennsylvania, September 14, 2016 — Center Point Clinical Services, provider of specialty clinical research and medical outcomes solutions, announced today that Tim Slavin has joined the company as its new senior director of clinical accounts.

“We are thrilled to welcome Tim to the Center Point Clinical Services family. His vast experience, informed perspective and true dedication is certain to have a positive impact on the company and its customers,” said Joe Martinez, CEO of Center Point Clinical Services.

“Center Point provides high quality solutions and unique specialty services that are proving instrumental in helping medical device and pharma companies to achieve their clinical study, regulatory and commercialization goals, in less time and more cost effectively than any other CRO.  The offering is extremely attractive and impressive. I am very pleased to be part of this worthy effort and looking forward to an exciting future,” said Mr. Slavin.

Mr. Slavin is a veteran in the medical industry. He served for decades in sales, account management and commercial team collaboration for a series of prominent companies.  These include Sunovion, Novo Nordisk, Amylin Pharmaceuticals, Ortho-McNeil Pharmaceuticals, and Novartis Nutrition. He was the recipient of Sunovion’s 2015 “Spotlight on Excellence” award as well as many sales performance awards throughout the years. He holds a B.S. in Business Administration from East Carolina University in Greenville, NC.

About Center Point Clinical Services

Center Point Clinical Services LLC. is a specialty contract research organization (CRO) that helps pharmaceutical, biotech, and medical device companies  successfully reach their regulatory and commercialization goals in less time and at a lower cost than competitors.    The company offers two premier signature services.  The first is the Clinical Trials Research Pharmacist (CTRP®) program, which uses only licensed, specially trained pharmacists to communicate with patients.  Center Point is the only CRO to offer such a unique and effective service.  CTRP has repeatedly demonstrated improved patient retention, medication compliance and overall outcomes in clinical trials.  The second service includes a series of practical signature study solutions intended to support regulatory and commercialization goals. These include: real world evidence (RWE) analysis and publications, health economic outcomes and research (HEOR), market access and reimbursement support, industry standard quality metrics data, and scientific publications. For more information please visit

Like us on Facebook

Follow us on Twitter and LinkedIn

Press Contact:

Marjie Hadad

MH Communications

1-844-287-2877 Ext 9





  • Case Study
    A Biopharmaceutical Company Sponsoring a Phase II Clinical Trial in the U.S.
  • Blog
    In One Year and Out the Other
    December 26, 2018
  • Need More Information?